Board

Home  >>  BioRN Network  >>  Board

Under the chairmanship of Prof. Dr. Stefan Meuer and together with renowned and committed persons from business and industry, the board is dedicated to the continual consolidation of the Biotech-Cluster Rhine-Neckar and to its further development towards a leading position in Europe.

Prof. Dr. Stefan Meuer (Chairman)

Managing Director of the Institute for Immunology, Heidelberg University

Dr. Jürgen Schwiezer (Deputy Chairman)

Former CEO of Diagnostics Division, Hoffmann-La Roche, Basel, Suisse

Dr. Sigfried Bialojan

Executive Director, Head of Life Science Center Mannheim, Ernst & Young GmbH, Mannheim

Prof. Dr. Bernd Bukau

Director, Center of Molecular Biology Heidelberg (ZMBH), Heidelberg University

Dr. Adrian Carter

Corporate Vice President of Research Networking, Boehringer Ingelheim

Dipl. Kfm. Michael Deissner

CEO, comForte 21 GmbH, Wiesbaden

Dr. Jürgen Gamer

VP Business Development, Apogenix AG, Heidelberg

Martin Haag

Site Manager Roche Diagnostics GmbH, Mannheim

Dr. Claus Kremoser

CEO Phenex Pharmaceuticals AG, Heidelberg

Dr. Georg Licht

Head of Department
Industrial Economics and International Management Centre for European Economic Research

Dr. Gitte Neubauer

CEO Cellzome, a GSK company

Dr. Wolfgang Niopek

Managing Director Rhine-Neckar Chamber of Industry and Commerce, Heidelberg

Dr. Martin Raditsch

CEO INNOVECTIS GmbH, Frankfurt

Dr. Volker Stadler

CEO, PEPperPRINT GmbH, Heidelberg

Dr. Christian Tidona

Managing Director, BioMed X GmbH, Heidelberg

Prof. Dr. Heike Andrea Wieland

Leader External Ecosystem R&D, Sanofi Aventis Deutschland GmbH, Frankfurt

Dr. Axel Wiest

Head of R & D, Merck, Darmstadt

Prof. Dr. Christoph von Kalle

Director, National Center of Tumor (NCT)